NASDAQ:MORF - Nasdaq - US61775R1059 - Common Stock - Currency: USD
TTM (2024-6-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
---|---|---|---|---|---|---|---|---|
Revenue | 0.00 | 521.00K | 70.81M | 19.79M | 44.95M | |||
Operating Expenses | 213.02M | 179.21M | 134.20M | 115.60M | 92.13M | |||
Research and Development | 165.92M | 140.38M | 102.06M | 87.79M | 73.63M | |||
Selling, General, and Administrative Expenses | 47.08M | 38.82M | 32.14M | 27.81M | 18.50M | |||
Operating Income | -213.02M | -178.69M | -63.40M | -95.81M | -47.18M | |||
Interest Income/Expense | 33.73M | 26.97M | 4.57M | 270.00K | 1.63M | |||
Other Income/Expense | -12.00K | 2.00K | -150.00K | -10.00K | -20.00K | |||
Income Before Taxes | -179.30M | -151.72M | -58.97M | -95.54M | -45.57M | |||
Income Tax | 527.00K | 380.00K | 70.00K | 0.00 | -570.00K | |||
Net Income | -179.82M | -152.09M | -59.04M | -95.54M | -45.00M | |||
EBITDA | -211.90M | -177.59M | -62.39M | -94.78M | -46.05M | |||
Per Share Data | ||||||||
EPS Diluted Total Ops | -3.72 | -3.59 | -1.55 | -2.67 | -1.47 | |||
Non GAAP EPS | -3.75 | -3.51 | -1.59 | -2.67 | -1.47 | |||
Statistics | ||||||||
Profit Margin | N/A | -29192.90% | -83.38% | -482.77% | -100.11% | |||
Operating Profit Margin | N/A | -34296.74% | -89.54% | -484.13% | -104.96% |
All data in USD